Autoimmunity and Chronic Inflammation Research

Verification processes at the humoral, cellular, and tissue levels for immune tolerance breakdown, autoantibodies, chronic inflammation, immune cell imbalance, and tissue damage.

Core Research Questions

  • Are there changes in autoantibodies, inflammatory factors, and complement-related signals?
  • Are the proportions and states of T/B cells and myeloid subpopulations abnormal?
  • How are tissue infiltration, damage, and repair-related markers distributed?
  • Can candidate interventions yield consistent results across multiple detection platforms?

Common Samples and Models

  • Serum, plasma, PBMC, and whole blood
  • Affected tissues, FFPE sections, and tissue lysates
  • Immune cell culture and stimulation models

Key Mechanisms and Observation Dimensions

  • Immune tolerance, B/T cell activation, and autoantibodies
  • Cytokines, complement, chemotaxis, and tissue infiltration
  • Chronic inflammation, fibrosis, and tissue damage repair

Recommended Experimental Workflows

Product Selection Entrance

Solution Design and Quality Requirements

It is recommended to predefine research hypotheses, primary endpoints, negative and positive controls, biological replicates, exclusion criteria, and statistical methods. Compatibility for different samples, species, platforms, and batches needs to be independently confirmed, and original data, reagent lot numbers, and key operational records should be retained.

Please provide when submitting an inquiry

  • Research objectives and mechanisms to be validated
  • Sample type, species, model, and estimated quantity
  • Planned experimental methods, instrument platforms, and throughput
  • Target analytes, required specifications, quality grade, and delivery region
  • Required instructions, SDS, CoA, or other quality documents

Submit product and technical inquiries for this research area

Research Use Statement: The content on this page is for research design, product selection, and technical communication purposes only, and does not constitute clinical diagnosis, treatment recommendations, or regulatory approval statements.